1-3 of 3
antirheumatic drugs, disease-modifying
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD
Journal: Blood
Blood (2015) 126 (23): 2954.
https://doi.org/10.1182/blood.V126.23.2954.2954
Published: 2015
Journal Articles

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

Richard A. Nash, Peter McSweeney, Leslie Crofford, Kevin T. McDonagh, Maureen Mayes, J. Lee Nelson, Ted Gooley, Leona Holmberg, Howard Shulman, Mark Wener, Bernadette McLaughlin, Gretchen Henstorf, Jerry Molitor, James Seibold, Keith Sullivan, Daniel Furst
Journal: Blood
Blood (2006) 108 (11): 3071.
https://doi.org/10.1182/blood.V108.11.3071.3071
Published: 2006
Journal Articles

Non-Hodgkin’s Lymphoma in the Context of Antecedent Rheumatoid Arthritis: A Case Series from the Mayo Clinic and the Nebraska Lymphoma Study Group.

Justin O. Endo, BS, Melissa G.M. Ooi, MBBCh, MRCP, Natalie A. Black, Patricia Aoun, MD, MPH, Thomas M. Habermann, MD, Julie A. Stoner, PhD, James O. Armitage, MD, Ted R. Mikuls, MD, MSPH
Journal: Blood
Blood (2004) 104 (11): 1382.
https://doi.org/10.1182/blood.V104.11.1382.1382
Published: 2004